Sagamore Investments
Tower 21, Beijing, 100028, China
Overview
Sagamore Investments is a fund of funds and private equity firm with offices in Beijing, China.
- Total investments
- 4
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 2
Investment portfolio
- Neat
Participated · Series A · Apr 2020
Neat is a Hong Kong-based fintech that offers online business accounts in multiple currencies, cross-border payment capabilities, and corporate credit cards for startups and small businesses. The company enables customers to open accounts online, send and receive payments from different countries, and apply for corporate cards, and it already offers a Neat Mastercard. Neat has a strategic partnership with Visa and will begin issuing Visa credit cards to SMEs and startups in the coming months. The startup plans to launch tools for automated payroll, accounting and logistics in the future. It has expanded geographically with a Shenzhen office to serve Chinese export businesses and a London office for Western European companies that trade in China. The recent $11M Series A will be used for expansion focused on Southeast Asian customers that trade with European companies, bringing total funding to $16.5M. Neat offers quick access to prepaid Mastercard-based cards and basic banking services for startups and SMEs, charging around $7.50 per month and variable fees on incoming, outgoing and international payments. The company also provides a consumer option similar to Monzo, Starling and Revolut, but focuses primarily on business users. Neat claims customers in 100 countries and has introduced international payments; it is working on multi-currency solutions and integrations with third-party services such as accountancy tools. The business is earlier stage and has previously raised a $2 million seed round earlier this year. Neat pulled in $3 million in fresh funding to expand its product and reach. With the new backing it aims to target Chinese businesses seeking banking options in Hong Kong while competing with established incumbents. Neat is a challenger bank focused on business banking for early-stage startups and SMEs, offering business accounts and debit-based Neat Mastercards. The service enables companies that cannot get credit cards to pay bills, flights, hotels and subscriptions without using personal cards, and supports payroll, invoicing, receipt of funds and employee expense cards. More advanced features are planned, including detailed company reporting, automated accounts, multi-currency solutions and accountancy software integrations to widen global appeal. Neat began with a consumer service in Hong Kong but places heavy emphasis on its business product and global expansion. The company was founded in 2015 by David Rosa and Igor Wos and is based in Hong Kong, with customers in over 100 countries. Financially, Neat recently raised $2 million to develop its technology and increase marketing, with participation from Dymon Asia and Portag3 Ventures.
- Stealth BioTherapeutics
Participated · Convertible Note · Jun 2018
Stealth BioTherapeutics focuses on developing therapies that directly address mitochondrial bioenergetic deficits across rare and age-related diseases. The company’s development portfolio includes elamipretide programs in Barth syndrome, polymerase gamma–related mitochondrial disease and dry age-related macular degeneration, a next-generation clinical candidate bevemipretide for ophthalmic and neurological indications, and preclinical assets SBT-255 and SBT-589 for rare mitochondrial disorders. Its parent, Mighty Therapeutics, achieved FDA approval in September 2025 for the first commercial therapy for Barth syndrome and the first FDA-approved therapy to directly target mitochondria, generating revenue from its lead commercial product. The company plans to use newly secured capital to accelerate commercial launch activities and advance late-stage and pipeline development programs. Financially, current cash, cash equivalents and product revenues are expected to extend runway into 2028, with additional financing drawdowns projected to support cash flow positivity in early 2029.
- Accion
Led · Equity · Jun 2012
Founded in 2009 by Accion, Accion Microfinance China (AMC) delivers working-capital and fixed-asset loans to urban and rural microentrepreneurs and small and medium-sized enterprises in the Chifeng region. Loan amounts start at RMB 1,000 and the institution focuses on previously underserved MSME segments. Since inception AMC has disbursed RMB 157m in loans to almost 2,000 clients, with an average outstanding loan of RMB 55,000. The organization has invested in staff training and built a local team of 37 full-time employees to support its clients. AMC’s market opportunity is framed by gaps in formal MSME financing in China and aligns with Chinese government efforts to address MSME funding challenges. Accion remains the operating partner of AMC following the new investment. ACCION Microfinance China (AMC) is a Chinese affiliate launched in December 2009 to expand financial access in Chifeng, Inner Mongolia. AMC provides working-capital and fixed-asset loans to thousands of urban and rural small and medium-sized enterprises. The organization focuses on serving previously underserved communities and local SMEs. IFC previously signed a cooperation agreement with ACCION to provide up to $1m to fund a three-year technical assistance program for AMC. The IFC investment announced is intended to strengthen AMC's operations. The articles do not report revenue figures or other financial metrics beyond the investment amount and the program financing.
Team
Rodrigo Y.C. Yang
Managing Director & Co-Founder
LinkedInPeter Brooks
Co-Founder & Managing Director